Of these, there was a statistically significant difference in the incidence of any AE, herpes zoster, hepatic disorder, increased CPK, neutropenia, acne, and atopic dermatitis, upadacitinib 15 mg versus placebo. This evidence concerns the gene PIK3C2A and neutropenia.